On this page
The field notes
Cienega offers a concrete comparison for California readers who want an assessment without a required subscription. The useful figure is the bottle plus review fee. Its separate blend and the evidence behind recovery claims still need to be read on their own terms.
What is on the record
- The bottle price and separate review fee are disclosed together.
- The pages explain a non-subscription order model and California fulfillment.
Read the small print
- A bottle price does not establish treatment duration.
- Exact preparation, assigned pharmacy and individual eligibility still require confirmation.
Open the published facts
- Published single-product price
- $199 per bottle, before the $49 medication review; not a monthly rate.
- Care model
- Prescription consultation with the Cienega team; California delivery and Los Angeles-area pickup described.
- Extra order charge
- One $49 medication review per order; the consultation itself is described as free.
- Subscription
- No required subscription or automatic refill on the reviewed single-product pages.
- Pharmacy check
- Provider says a licensed U.S.503A pharmacy fills the prescription; individual facility and licenses not independently verified.
Based on published information. Sources checked October 2026.
Start with the location limit
The current BPC-157 page explicitly addresses California residents and describes phone or video assessment. Pickup is offered at Los Angeles-area clinics, with California delivery described as free. That is a meaningful service distinction, but it is not a nationwide telehealth offer. Check the current eligibility for your address before treating it as an alternative to a service in another state.
Add the charge that follows the free visit
The page displays a $199 BPC-157 bottle and adds a $49 medication review when an order is made. The one-bottle arithmetic example is therefore $248. Keep that separate from any optional additional bottle, blend or future encounter. A free initial conversation does not make the prescription review or medication free.
A single molecule and a blend are different comparisons
The page also presents a BPC-157/KPV/TB-500 blend. It should not be treated as the same product with a different brand name. Ask the clinician to identify the exact formulation and rationale, then read the research evidence for the claimed outcome. Inclusion of a familiar peptide does not make evidence for a standalone preparation evidence for a combination.
The next useful questions concern the exact prescription
Ask for the dispensing pharmacy, the product label, the follow-up arrangement and what happens if the clinician does not recommend treatment. These are more useful than assuming that a professional title or a large clinic review count verifies every part of the service. This review covers published documents; it does not report a patient visit, independent license check or examination of a dispensed product.
Keep a record before making the next commitment
Save the written order and the terms that apply to it. A cancellation, an unused bottle and a refund after dispensing are different situations; ask the provider to explain each before payment. The consultation checklist helps turn those open questions into a practical discussion. Product availability and the clinical assessment can change, so an older quote should not be treated as a promise of future access.
Sources & further reading
Primary research, provider documents and policy sources used in this article. Sources do not endorse this publication.
Source review: 2026-10-29. Provider terms and policy documents can change.